We recently compiled a list of the 10 Best Performing Small-Cap Stocks in 2024. In this article, we will look at where Viking ...

Analyst Justin Zelin from BTIG reiterated a Buy rating on Jasper Therapeutics (JSPR – Research Report) and keeping the price target at ...

Viking Therapeutics (NASDAQ: VKTX), a biotech stock that has rocketed to prominence thanks to one of its investigational ...

I'm bullish on Viking Therapeutics' weight-loss drug, but warn of risks and competition ahead. Click here to read my most ...

Viking Therapeutics, Inc.'s stock surged 1,500% on the promising obesity drug VK-2735, with Phase 3 trials and potential for ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Let the speculation begin. On the September 23 episode of WWE RAW, a brief teaser aired. A flaming circle appeared on screen, ...

Several launches in 2027 (Amgen, Altimmune), 2028 (Pfizer, Roche, Viking, and Structure), and 2029 (Roche, Viking, ...

Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $70.47 which represents a slight increase of $2.31 or 3.39% from the prior close of $68.16. The stock opened at $69.5 and ...

Insights from Historical Trends ...

Because this plan is a short plan based on a test of resistance it is referred to as a Short Resistance Plan. Check the time stamp on this data. Updated AI-Generated Signals for Viking Therapeutics ...

The weight-loss drug market has exploded over the past year, fueled by blockbuster GLP-1 breakthroughs from pharma giants.